|
PSIMCT-1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57429996711289E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15489999785723E-08 |
| Normal-vs-Stage2 |
4.20709999999769E-05 |
| Normal-vs-Stage3 |
7.908299570758E-10 |
| Normal-vs-Stage4 |
9.77629976972594E-10 |
| Stage1-vs-Stage2 |
2.224000E-01 |
| Stage1-vs-Stage3 |
1.750770E-01 |
| Stage1-vs-Stage4 |
1.159580E-01 |
| Stage2-vs-Stage3 |
3.086200E-02 |
| Stage2-vs-Stage4 |
2.828000E-02 |
| Stage3-vs-Stage4 |
7.729200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9046000049604E-09 |
| Normal-vs-AfricanAmerican |
2.12889999995358E-06 |
| Normal-vs-Asian |
7.98150000536069E-08 |
| Caucasian-vs-AfricanAmerican |
9.716600E-01 |
| Caucasian-vs-Asian |
9.899800E-01 |
| AfricanAmerican-vs-Asian |
9.667600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.33320063059273E-11 |
| Normal-vs-Female |
5.07209996225555E-09 |
| Male-vs-Female |
6.462600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.88420001612633E-09 |
| Normal-vs-Age(41-60Yrs) |
6.53039999853888E-09 |
| Normal-vs-Age(61-80Yrs) |
8.11320000071447E-09 |
| Normal-vs-Age(81-100Yrs) |
3.619600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.223600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.749000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.019600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.272000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.797000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.222200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.481600E-03 |
| Classical-VS-Follicular |
3.010200E-01 |
| Classical-VS-Other |
4.566200E-01 |
| Classical-VS-Normal |
1.98899999803714E-08 |
| Tall-VS-Follicular |
1.737110E-03 |
| Tall-VS-Other |
8.099800E-01 |
| Tall-VS-Normal |
5.07229813706545E-11 |
| Follicular-VS-Other |
3.630600E-01 |
| Follicular-VS-Normal |
7.85420000037895E-07 |
| Other-VS-Normal |
6.044600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92789999520215E-08 |
| Normal-vs-N1 |
4.06380484818669E-11 |
| N0-vs-N1 |
6.716800E-03 |
|
|
